This randomized, parallel-design trial will evaluate specific clinical and physiological effects of whole blueberries in adults 70 years of age or older.
Although much is already known about the benefits of a healthy diet for the prevention of a wide range of chronic diseases, including the particular health benefits of anthocyanin-rich foods, these effects have been examined with much less frequency in older adults, who tend to be excluded from formal feeding studies and, until recently, have represented a small proportion of ongoing cohort studies. The proposed study will randomize approximately 46 women and 24 men, representative of the proportion of elderly women and men in the U.S. to consume either: 1. 1 cup of frozen blueberries daily for 12 weeks or 2. 2-3 dried dates daily for 12 weeks. Dates were chosen as a control food because they contain negligible polyphenols, proportionately high caloric content, and a convenient form for storage. After the 12-week intervention, researchers will repeat in-person study assessments from baseline.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
61
Participants will consume 1 cup of frozen blueberries daily for the 12 weeks of the intervention. The study dietitian will provide educational materials and monitor compliance through weekly check-ins. Participants will be instructed to avoid all other high-anthocyanin foods including other berries, cherries, currants, cabbage, red wine, and eggplant.
Participants will consume 2-3 dried dates daily for the 12 weeks of the intervention, an isocaloric portion of fruit compared to the blueberry group. The study dietitian will provide educational materials and monitor compliance through weekly check-ins. Participants will be instructed to avoid all other high-anthocyanin foods including blueberries, other berries, cherries, currants, cabbage, red wine, and eggplant.
Center Communities of Brookline (CCB)
Brookline, Massachusetts, United States
NewBridge on the Charles
Dedham, Massachusetts, United States
Ambulatory Blood Pressure Monitoring
24-hour wake-time ambulatory blood pressure monitoring
Time frame: 12 weeks after randomization
Orthostatic Hypotension
Supine and standing blood pressure
Time frame: 12-weeks after randomization
Lower Extremity Functioning
Short Physical Performance Battery
Time frame: 12 weeks after randomization
Cognition
Cogstate Brief Battery of four core cognitive domains: processing speed, attention, visual learning, and working memory
Time frame: 12 weeks after randomization
Number of Self-Reported Falls
Investigators will administer the Fall Follow-Up Questionnaire from the Study to Understand Fall Reduction and Vitamin D in You (STURDY) to participants that self-report falls to record details on each fall.
Time frame: Weekly for 12 weeks between baseline and follow-up
Grip Strength
Bilateral grip strength measured by a dynamometer
Time frame: 12 weeks after randomization
Sleep
Pittsburgh Sleep Quality Index. The 19 self-rated items are combined to form 7 "component" scores, each of which has a range of 0-3 points. In all cases, a score of "0" indicates no difficulty, while a score of "3" indicates severe difficulty. The 7 component scores are then added to yield one "global score", with a range of 0-21 points, "0" indicating no difficulty and "21" indicated severe difficulties in all sleep areas.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 weeks after randomization
Incontinence
Questionnaire for Urinary Incontinence Diagnosis. The first 3 items focus on stress incontinence symptoms and the last 3 on urge incontinence symptoms. Each item includes 6 frequency-based response options, which are scored from 0 to 5 points. Scores are calculated in an additive fashion, resulting in separate Stress and Urge score, each ranging from 0-15 points. Higher scores indicate more severe incontinence symptoms.
Time frame: 12 weeks after randomization
Cardiac Ectopy
Number of participants with atrial premature beats detected by a 24-hour Holter monitor
Time frame: 12 weeks after randomization
Troponin T (HS)
Measured in blood sample
Time frame: 12 weeks after randomization
High Density Lipoprotein Cholesterol
Measured in fasted blood as part of a lipid panel
Time frame: 12 weeks after randomization
Total Cholesterol
Measured in fasted blood as part of a lipid panel
Time frame: 12 weeks after randomization
Derived Low Density Lipoprotein Cholesterol
Measured in fasted blood as part of a lipid panel
Time frame: 12 weeks after randomization
Triglycerides
Measured in fasted blood as part of a lipid panel
Time frame: 12 weeks after randomization
Estimated Glomerular Filtration Rate (eGFR)
Measured in blood as part of basic metabolic panel
Time frame: 12 weeks after randomization
Albumin-to-Creatinine Ratio
Measured in a spot urine sample to detect albuminuria
Time frame: 12 weeks after randomization
Fructosamine
Measured in blood to estimate glucose levels over the previous 2-3 weeks.
Time frame: 12 weeks after randomization
Free Fatty Acids
Measured in blood samples
Time frame: 12 weeks after randomization
C-Reactive Protein (CRP)
Measured concentration in blood in response to inflammation
Time frame: 12 weeks after randomization
C-terminal telopeptide of type 1 collagen
Measured in blood samples to assess bone turnover
Time frame: 12 weeks after randomization
T-Cell Receptor Portfolio
Adaptive Immune Receptor Repertoire sequences in blood samples
Time frame: 12 weeks after randomization
Immune System Diversity
Measure in blood samples to show diversity of immune sequences
Time frame: 12 weeks after randomization